Puma Biotechnology (PBYI) Interest & Investment Income (2012 - 2026)
Puma Biotechnology (PBYI) posted Interest & Investment Income of $1.0 million for Q1 2026, up 2.56% on a QoQ basis from $977000.0 in Q4 2025, and down 8.99% year-over-year from $1.1 million in Q1 2025.
Puma Biotechnology (PBYI) Interest & Investment Income (2012 - 2026) Analysis & Trends
Puma Biotechnology's Interest & Investment Income history runs 15 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- Quarterly Interest & Investment Income fell 8.99% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (down 18.01% YoY) and the FY2025 annual result came in at $4.1 million, down 13.67% from the prior year.
- Interest & Investment Income was $1.0 million for Q1 2026 at Puma Biotechnology, up from $977000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.3 million in Q3 2024 and bottomed at $13000.0 in Q1 2022.
- A 5-year average of $777764.7 and a median of $956000.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income sank 46.28% — and 2023, when it jumped 4030.77%.
- Puma Biotechnology's Interest & Investment Income stood at $519000.0 in 2022, then jumped by 38.54% to $719000.0 in 2023, then surged by 70.51% to $1.2 million in 2024, then declined by 20.31% to $977000.0 in 2025, then climbed by 2.56% to $1.0 million in 2026.
- Business Quant data shows PBYI's Interest & Investment Income at $1.0 million in Q1 2026, $977000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Puma Biotechnology | 406.51 Mn | 368.22 Mn | 34.39 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 977,000.00 |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 956,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | 972,000.00 |
| Dec 31, 2023 | 719,000.00 |
| Sep 30, 2023 | 689,000.00 |
| Jun 30, 2023 | 660,000.00 |
| Mar 31, 2023 | 537,000.00 |
| Dec 31, 2022 | 519,000.00 |
| Sep 30, 2022 | 216,000.00 |
| Jun 30, 2022 | 65,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 121,000.00 |